Dallas, Texas, United States In 2006 was created Scientific Health Development Partners, which is appeared as VC. The main department of described VC is located in the Dallas. The company was established in North America in United States.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Scientific Health Development Partners, startups are often financed by InCube Ventures, Boston Scientific, Aperture Venture Partners. The meaningful sponsors for the fund in investment in the same round are Third Point Ventures, MIT Alumni Angels of Northern California, Longwood Founders Fund. In the next rounds fund is usually obtained by Third Point Ventures, Primer Capital, MidCap Financial.
Comparing to the other companies, this Scientific Health Development Partners performs on 20 percentage points less the average number of lead investments. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2018. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars.
We can highlight the next thriving fund investment areas, such as Biotechnology, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Channel Medsystems, Procyrion, CureDM. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Accelerate Michigan Innovation Competition | Detroit, Michigan, United States |
| Arcview Collective Fund | California, San Francisco, United States |
| ATA | Beijing, Beijing, China |
| Banco do Brasil | Brasília, Brazil, Rio Grande do Norte |
| Bank of Sharjah | Dubai, United Arab Emirates |
| CEE Group | - |
| Cook Inlet Region, Incorporated | - |
| Eventpop | Bangkok, Krung Thep, Thailand |
| Forcadell | Barcelona, Catalonia, Spain |
| Freemark holdings | - |
| Ionian Ventures | New York, New York, United States |
| LG Chem | Seoul, Seoul-t'ukpyolsi, South Korea |
| Marshall Capital Corporation | Canada, Ontario, Toronto |
| Security Bank Corporation | Makati, Manila, Philippines |
| Suzhou International Development Venture Capital | China, Jiangsu, Suzhou |
| The Todd & Rahul Angel Fund | - |
| Unaxis Optics | - |
| UnitedHealthcare Accelerator Powered by Techstars | Minneapolis, Minnesota, United States |
| Xiaoyang Touzi | China, Guangdong Province, Longgang District |
| Zhuhai Hengqin Yicheng Guanli Zixun Qiye | China, Guangdong, Zhuhai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Liberate Medical | $6M | 05 Jul 2023 | Kentucky, United States | ||
Podimetrics | $45M | 24 Mar 2022 | Massachusetts, United States | ||
Koya Medical | $26M | 03 Feb 2022 | Oakland, California, United States | ||
Empirical Spine | $10M | 02 Jun 2021 | California, United States | ||
MiNDERA Corporation | $12M | 12 May 2021 | South San Francisco, California, United States | ||
Koya Medical | $11M | 14 Jan 2021 | Oakland, California, United States | ||
Podimetrics | $8M | 19 Aug 2020 | United States, " United States"} | ||
Podimetrics | $13M | 09 May 2019 | United States, " United States"} | ||
Procyrion | $16M | 31 Jan 2018 | Houston, Texas, United States |
– Mindera Corporation from San Diego, develops a dermal biomarker patch for skin analytics at the molecular level.
– The company raised $12.6M in Series A-2 funding.
– The round was led by Mountain Group Partners, Rockmont Investments, and Scientific Health Development.
– The new investment will be aimed at commercializing Mind.Px, a tool to prospectively predict patient response to expensive psoriasis biologics, as well as continuing development of the Mindera Dermal Intelligence™ Platform.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Liberate Medical | $6M | 05 Jul 2023 | Kentucky, United States | ||
Podimetrics | $45M | 24 Mar 2022 | Massachusetts, United States | ||
Koya Medical | $26M | 03 Feb 2022 | Oakland, California, United States | ||
Empirical Spine | $10M | 02 Jun 2021 | California, United States | ||
MiNDERA Corporation | $12M | 12 May 2021 | South San Francisco, California, United States | ||
Koya Medical | $11M | 14 Jan 2021 | Oakland, California, United States | ||
Podimetrics | $8M | 19 Aug 2020 | United States, " United States"} | ||
Podimetrics | $13M | 09 May 2019 | United States, " United States"} | ||
Procyrion | $16M | 31 Jan 2018 | Houston, Texas, United States |
